'Circulating' RNA-based therapies in Cardio-Oncology

Eur Heart J. 2022 Nov 7;43(42):4512-4514. doi: 10.1093/eurheartj/ehac407.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Cardiotoxicity
  • Cell-Free Nucleic Acids*
  • Doxorubicin
  • Humans
  • Neoplasms* / genetics
  • Neoplasms* / therapy
  • RNA, Circular
  • Receptor, Insulin

Substances

  • RNA, Circular
  • Cell-Free Nucleic Acids
  • Receptor, Insulin
  • Doxorubicin